Last year, the FDA approved the biologic drug Dupixent to treat uncontrolled eosinophilic COPD. The approval marked a step ...

AstraZeneca's three-drug inhaler Breztri Aerosphere has shown efficacy for uncontrolled asthma in a pair of phase 3 trials ...

Asthma, a chronic respiratory disease affecting over 262 million people globally, poses a significant public health challenge ...

While genetics can increase a person's likelihood of developing asthma, high pollution and exposure to harmful environmental ...

AstraZeneca has taken a key step in advancing Breztri Aerosphere toward a potential label expansion and achieving its goal of ...

India reportedly has the highest asthma-related deaths in the world, accounting for nearly 46% of them. With over 34 million ...

Given the rising prevalence of cognitive impairment in COPD, researchers have called for increased efforts to identify risk factors and intervene earlier.

Nov. 27, 2024 — A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further ...

The replicate confirmatory KALOS and LOGOS trials evaluated BGF in participants with severe asthma inadequately controlled with standard of care.

On the FDA’s docket this month are two expansion bids, one for GSK’s asthma drug Nucala into COPD and another for Merck’s ...

Top-line data from Phase 2 clinical trial of verekitug in patients with chronic rhinosinusitis with nasal polyps expected in ...